Prescription Drug Pricing

Prescription drug prices in America are far too high. As a result, 31 percent of Americans can’t afford to take their medications as prescribed. Recent reforms in the Inflation Reduction Act, including Medicare drug price negotiation, are making substantial progress toward lowering prescription drug prices, but there is still much work to do to help Americans afford the medications they need. The Center for American Progress analyzes and advocates for policy solutions to counteract the excessive prices set by pharmaceutical companies, including: advocating for direct price negotiation and price controls, combating manufacturer delay tactics, reforming the patent process, and promoting greater federal oversight and intervention.

Photo shows a closeup of a person's hands opening a bottle of pills, with a blue pill organizer sitting in front of them
A person with multiple sclerosis sorts prescription pills, June 2019. (Getty/Kurt Wittman/UCG/Universal Images Group)
Related Team
Health Policy

Latest

Compact View

CAP Responds to Request for Information on Consolidation in Health Care Markets Article

CAP Responds to Request for Information on Consolidation in Health Care Markets

The Center for American Progress submitted a response to the U.S. Department of Justice, Federal Trade Commission, and U.S. Department of Health and Human Services’ request for information on consolidation in health care markets.

Monthly Medicare Drug Price Negotiation Savings by State Interactive
Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy in Chicago.

Monthly Medicare Drug Price Negotiation Savings by State

Medicare drug price negotiation will result in thousands of dollars in net price savings for 30-day supplies of the first 10 drugs undergoing negotiation; here’s how those savings add up state by state.

Nicole Rapfogel

5 Things To Know About Pharmacy Benefit Managers Article

5 Things To Know About Pharmacy Benefit Managers

Pharmacy benefit managers are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers.

Nicole Rapfogel

CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices Article

CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices

These briefs emphasize the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity.

CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices Article

CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices

This brief, filed by the Center for American Progress and the NAACP in response to Boehringer Ingelheim Pharmaceuticals Inc. v. U.S. Department of Health and Human Services et al., emphasizes the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity.

Drug Companies Continue To Hike Prices Above Inflation Article
Bottles of prescription drugs are filled as they move down an automated line at a pharmacy

Drug Companies Continue To Hike Prices Above Inflation

New analysis makes clear that the Inflation Reduction Act’s inflation rebates should extend to the commercial market.

Nicole Rapfogel

Medicare Drug Price Negotiation Will Help Millions of Seniors and Improve Health Equity Article
Photo shows three orange prescription drug bottles—one full with the cap off, and two next to it with the caps screwed on—on an assembly line

Medicare Drug Price Negotiation Will Help Millions of Seniors and Improve Health Equity

The Inflation Reduction Act’s Medicare drug price negotiation provision will improve access to and affordability of medications that help women, Black, Hispanic or Latino, LGBTQI+, and disabled beneficiaries.

Gillian Tisdale, Nicole Rapfogel

Medicare Drug Price Negotiation Could Benefit Millions of Seniors Article

Medicare Drug Price Negotiation Could Benefit Millions of Seniors

The first 10 drugs negotiated under the Inflation Reduction Act are likely to include treatments for chronic conditions—such as diabetes, cancer, and autoimmune disorders—and be used by millions of beneficiaries.

Nicole Rapfogel

Load More

Related Issue

Strengthening Health

Strengthening Health

We work to strengthen public health systems and improve health care coverage, access, and affordability.

This field is hidden when viewing the form

Default Opt Ins

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

Variable Opt Ins

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.